Plain Language Summary: managing metastatic prostate cancer by integrating radium-223 therapy

This Plain Language Summary Publication from Future Oncology provides an overview of the current treatments available for metastatic castration-resistant prostate cancer (mCRPC) and also looks at what might be the best timing to use radium-223 therapy.

Read the full article here. 

• advanced prostate cancer
• bone metastases
• metastatic castration-resistant prostate cancer
• prostate cancer
• radium-223